BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37349537)

  • 1. The airway microbiome mediates the interaction between environmental exposure and respiratory health in humans.
    Lin L; Yi X; Liu H; Meng R; Li S; Liu X; Yang J; Xu Y; Li C; Wang Y; Xiao N; Li H; Liu Z; Xiang Z; Shu W; Guan WJ; Zheng XY; Sun J; Wang Z
    Nat Med; 2023 Jul; 29(7):1750-1759. PubMed ID: 37349537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway microbiome is associated with respiratory functions and responses to ambient particulate matter exposure.
    Wang L; Cheng H; Wang D; Zhao B; Zhang J; Cheng L; Yao P; Di Narzo A; Shen Y; Yu J; Li Y; Xu S; Chen J; Fan L; Lu J; Jiang J; Zhou Y; Wang C; Zhang Z; Hao K
    Ecotoxicol Environ Saf; 2019 Jan; 167():269-277. PubMed ID: 30342360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
    Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
    J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
    Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
    Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
    Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
    Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
    PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
    Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
    Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
    Huang YJ; Boushey HA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal Dynamics of the Upper Respiratory Tract Microbiome in Chronic Obstructive Pulmonary Disease.
    Cai S; Gao J; Liu X; Yang J; Feng D; Li G; Li S; Yang H; Wang Z; Yi X; Zhou Y
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1267-1276. PubMed ID: 37362620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling Microbiota from Multiple Sites in the Respiratory Tract to Identify a Biomarker for PM
    Zhang J; Cheng H; Di Narzo A; Zhu Y; Xie S; Shao X; Zhang Z; Chung SK; Hao K
    Environ Sci Technol; 2023 May; 57(19):7346-7357. PubMed ID: 37133311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures.
    Ghosh A; Saha S
    J Med Microbiol; 2022 Dec; 72(12):. PubMed ID: 36748565
    [No Abstract]   [Full Text] [Related]  

  • 12. Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease.
    Mac Aogáin M; Lau KJX; Cai Z; Kumar Narayana J; Purbojati RW; Drautz-Moses DI; Gaultier NE; Jaggi TK; Tiew PY; Ong TH; Siyue Koh M; Lim Yick Hou A; Abisheganaden JA; Tsaneva-Atanasova K; Schuster SC; Chotirmall SH
    Am J Respir Crit Care Med; 2020 Aug; 202(3):433-447. PubMed ID: 32320621
    [No Abstract]   [Full Text] [Related]  

  • 13. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Wang Z; Singh R; Miller BE; Tal-Singer R; Van Horn S; Tomsho L; Mackay A; Allinson JP; Webb AJ; Brookes AJ; George LM; Barker B; Kolsum U; Donnelly LE; Belchamber K; Barnes PJ; Singh D; Brightling CE; Donaldson GC; Wedzicha JA; Brown JR;
    Thorax; 2018 Apr; 73(4):331-338. PubMed ID: 29269441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.
    Xiao W; Du LY; Mao B; Miao TW; Fu JJ
    BMJ Open; 2019 Nov; 9(11):e034592. PubMed ID: 31690612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD.
    Balbi B; Sangiorgi C; Gnemmi I; Ferrarotti I; Vallese D; Paracchini E; Delle Donne L; Corda L; Baderna P; Corsico A; Carone M; Brun P; Cappello F; Ricciardolo FL; Ruggeri P; Mumby S; Adcock IM; Caramori G; Di Stefano A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1879-1893. PubMed ID: 31686800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term exposure to high ambient air pollution increases airway inflammation and respiratory symptoms in chronic obstructive pulmonary disease patients in Beijing, China.
    Wu S; Ni Y; Li H; Pan L; Yang D; Baccarelli AA; Deng F; Chen Y; Shima M; Guo X
    Environ Int; 2016 Sep; 94():76-82. PubMed ID: 27209003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
    Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway microbial communities, smoking and asthma in a general population sample.
    Turek EM; Cox MJ; Hunter M; Hui J; James P; Willis-Owen SAG; Cuthbertson L; James A; Musk AW; Moffatt MF; Cookson WOCM
    EBioMedicine; 2021 Sep; 71():103538. PubMed ID: 34425308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.